Narayanaswamy Radhakrishnan, Wai Lam Kok, Esa Norhaizan Mohd
Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Bio Waste Management Laboratory, Vel Tech Technology Incubator, Veltech Dr. RR & Dr. SR University, 400 Feet Outer Ring Road, Avadi, Chennai, Tamil Nadu, India.
Pharmacogn Mag. 2017 Oct;13(Suppl 3):S512-S518. doi: 10.4103/pm.pm_195_16. Epub 2017 Oct 11.
The phytoconstituents phytic acid and 4-hydroxyisoleucine have been reported to posses various biological properties.
This prompted us to carry out the docking study on these two ligands (phytic acid & 4-hydroxyisoleucine) against eleven targeted enzymes.
Phytic acid & 4-hydroxyisoleucine were evaluated on the docking behaviour of cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-2 (mPGES-2), tyrosinase, human neutrophil elastase (HNE), matrix metalloproteinase (MMP 2 and 9), xanthine oxidase (XO), squalene synthase (SQS), nitric oxide synthase (NOS), human aldose reductase (HAR) and lipoxygenase (LOX) using Discovery Studio Version 3.1 (except for LOX, where Autodock 4.2 tool was used).
Docking and binding free energy analysis revealed that phytic acid exhibited the maximum binding energy for four target enzymes such as COX-2, mPGES-2, tyrosinase and HNE. Interestingly, we found that 4-hydroxyisoleucine has the potential to dock and bind with all of the eleven targeted enzymes.
This present study has paved a new insight in understanding 4-hydroxyisoleucine as potential inhibitor against COX-2, mPGES-2, tyrosinase, HNE, MMP 2, MMP 9, XO, SQS, NOS, HAR and LOX.
4-hydroxyisoleucine has the potential to dock and bind with all 11targeted enzymes such as (cyclooxygenase-2 [COX-2], microsomal prostaglandin E synthase-2 [mPGES-2], tyrosinase, human neutrophil elastase [HNE], matrix metalloproteinase [MMP-2 and -9], xanthine oxidase, squalene synthase, nitric oxide synthase, human aldose reductase, and lipoxygenase)Moreover, docking studies and binding free energy calculations revealed that phytic acid exhibited the maximum binding energy for four target enzymes such as COX-2, mPGES-2, tyrosinase, and HNE; however, for other six target enzymes, it fails to dock. COX-2: Cyclooxygenase-2, mPGES-2: Microsomal prostaglandin E synthase-2, HNE: Human neutrophil elastase, MMP-2 and -9: Matrix metalloproteinase-2 and -9, XO: Xanthine oxidase, SQS: Squalene synthase, NOS: Nitric oxide synthase, HAR: Human aldose reductase, LOX: Lipoxygenase, ADME: Absorption, distribution, metabolism, and excretion, TOPKAT: Toxicity Prediction by Computer-assisted Technology.
据报道,植物成分植酸和4-羟基异亮氨酸具有多种生物学特性。
这促使我们对这两种配体(植酸和4-羟基异亮氨酸)与11种靶向酶进行对接研究。
使用Discovery Studio Version 3.1评估植酸和4-羟基异亮氨酸对环氧合酶-2(COX-2)、微粒体前列腺素E合酶-2(mPGES-2)、酪氨酸酶、人中性粒细胞弹性蛋白酶(HNE)、基质金属蛋白酶(MMP 2和9)、黄嘌呤氧化酶(XO)、角鲨烯合酶(SQS)、一氧化氮合酶(NOS)、人醛糖还原酶(HAR)和脂氧合酶(LOX)的对接行为(脂氧合酶除外,其使用Autodock 4.2工具)。
对接和结合自由能分析表明,植酸对四种靶酶(如COX-2、mPGES-2、酪氨酸酶和HNE)表现出最大结合能。有趣的是,我们发现4-羟基异亮氨酸有可能与所有11种靶向酶对接并结合。
本研究为理解4-羟基异亮氨酸作为COX-2、mPGES-2、酪氨酸酶、HNE、MMP 2、MMP 9、XO、SQS、NOS、HAR和LOX的潜在抑制剂提供了新的见解。
4-羟基异亮氨酸有可能与所有11种靶向酶(如环氧合酶-2 [COX-2]、微粒体前列腺素E合酶-2 [mPGES-2]、酪氨酸酶、人中性粒细胞弹性蛋白酶 [HNE]、基质金属蛋白酶 [MMP-2和-9]、黄嘌呤氧化酶、角鲨烯合酶、一氧化氮合酶、人醛糖还原酶和脂氧合酶)对接并结合。此外,对接研究和结合自由能计算表明,植酸对四种靶酶(如COX-2、mPGES-2、酪氨酸酶和HNE)表现出最大结合能;然而,对于其他六种靶酶,它未能对接。COX-2:环氧合酶-2,mPGES-2:微粒体前列腺素E合酶-2,HNE:人中性粒细胞弹性蛋白酶,MMP-2和-9:基质金属蛋白酶-2和-9,XO:黄嘌呤氧化酶,SQS:角鲨烯合酶,NOS:一氧化氮合酶,HAR:人醛糖还原酶,LOX:脂氧合酶,ADME:吸收、分布、代谢和排泄,TOPKAT:计算机辅助技术毒性预测